We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$6.72B
AUM Growth
+$1.74B
Cap. Flow
+$1.32B
Cap. Flow %
19.66%
Top 10 Hldgs %
12.33%
Holding
3,576
New
994
Increased
941
Reduced
756
Closed
848

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$29.9M
2
NFLX icon
Netflix
NFLX
+$27M
3
XOM icon
ExxonMobil
XOM
+$17.6M
4
NKE icon
Nike
NKE
+$15.3M
5
MSFT icon
Microsoft
MSFT
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 3.9%
2 Consumer Discretionary 3.81%
3 Financials 1.58%
4 Communication Services 1.54%
5 Industrials 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCTY
2626
The9 Ltd
NCTY
$72.5M
$7.86K ﹤0.01%
+1,052
New +$8.52K
PEV
2627
DELISTED
Phoenix Motor Inc. Common Stock
PEV
$7.68K ﹤0.01%
+10,414
New +$7.97K
XWEL icon
2628
XWELL
XWEL
$8.78M
$7.6K ﹤0.01%
1,894
-654
-26% -$3.4K
MBRX icon
2629
Moleculin Biotech
MBRX
$2.89M
$7.59K ﹤0.01%
35
-1
-3% -$264
HSTO
2630
DELISTED
Histogen Inc. Common Stock
HSTO
$7.46K ﹤0.01%
10,491
-2,332
-18% -$2.09K
SOPA
2631
DELISTED
Society Pass
SOPA
$7.32K ﹤0.01%
+962
New +$11.6K
AVTX icon
2632
Avalo Therapeutics
AVTX
$980M
$7.29K ﹤0.01%
+86
New +$57.9K
BLPH
2633
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$7.14K ﹤0.01%
+10,355
New +$66.7K
BJDX icon
2634
Bluejay Diagnostics
BJDX
$1.03M
$7.12K ﹤0.01%
+1
New +$9.04K
JZXN icon
2635
Jiuzi Holdings
JZXN
$836K
$7.12K ﹤0.01%
5
+1
+25% +$1.5K
VRAX icon
2636
Virax Biolabs
VRAX
$2.38M
$7.08K ﹤0.01%
73
-26
-26% -$2.86K
HUBC icon
2637
Hub Cyber Security
HUBC
$5.65M
0
AMPE
2638
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7.02K ﹤0.01%
1,507
+813
+117% +$3.98K
AWIN
2639
DELISTED
AERWINS Technologies Inc
AWIN
$6.95K ﹤0.01%
165
-750
-82% -$48.2K
AEY
2640
DELISTED
ADDvantage Technologies Group
AEY
$6.94K ﹤0.01%
+1,119
New +$8.94K
AIM
2641
AIM ImmunoTech
AIM
$7.29M
$6.9K ﹤0.01%
103
-63
-38% -$3.04K
NEXI
2642
DELISTED
NexImmune, Inc. Common Stock
NEXI
$6.69K ﹤0.01%
+949
New +$8.18K
UPC icon
2643
Universe Pharmaceuticals Inc
UPC
$4.57M
$6.65K ﹤0.01%
+5
New +$10.8K
GCTK icon
2644
GlucoTrack
GCTK
$4.62M
$6.57K ﹤0.01%
+3
New +$10.8K
CPHI icon
2645
China Pharma Holdings
CPHI
$47.8M
$6.55K ﹤0.01%
+384
New +$6.75K
AEMD icon
2646
Aethlon Medical
AEMD
$1.85M
$6.53K ﹤0.01%
5
NEPT
2647
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$6.52K ﹤0.01%
+1,109
New +$15.8K
ALPS
2648
DELISTED
Alpine Summit Energy Partners
ALPS
$6.41K ﹤0.01%
+10,689
New +$7.59K
VVOS icon
2649
Vivos Therapeutics
VVOS
$6.42M
$6.32K ﹤0.01%
+495
New +$4.85K
RDGT
2650
Ridgetech Inc
RDGT
$2.62M
$6.3K ﹤0.01%
+5
New +$19.3K

Similar funds

Two Sigma Securities's Q2 2023 Portfolio in Review

As of Q2 2023, Two Sigma Securities held 3,576 positions worth $6.72B, up 35% from $4.99B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Securities deployed $1.32B of net new capital in Q2 2023, opening 994 new positions and adding to 941 existing holdings. Its largest new stake was Netflix: 732,800 shares worth $32.3M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4.3% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.9M trimmed.

  • Two Sigma Securities's largest Q2 2023 buy was Netflix: 732,800 shares worth $32.3M.
  • Two Sigma Securities added most to Apple in Q2 2023, an estimated $29.9M increase.
  • Two Sigma Securities's biggest Q2 2023 reduction was Advanced Micro Devices, cutting an estimated $19.9M.
  • Two Sigma Securities fully exited Occidental Petroleum in Q2 2023, selling an estimated $16.8M.
  • Two Sigma Securities's ten largest holdings make up 12% of its $6.72B portfolio in Q2 2023.
  • Two Sigma Securities opened 994 new positions and closed 848 in Q2 2023.
  • Two Sigma Securities's portfolio value rose 35% quarter-over-quarter to $6.72B.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.